* Cerus Corp CERS.OQ reported a quarterly adjusted loss of
1
cent per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -8
cents. The mean expectation of five analysts for the quarter
was for a loss of 2 cents per share. Wall Street expected
results to range from -3 cents to -1 cents per share.
* Revenue rose 6.2% to $46.77 million from a year ago;
analysts
expected $49.27 million.
* Cerus Corp's reported EPS for the quarter was a loss of 1
cent.
* The company reported a quarterly loss of $1.33 million.
* Cerus Corp shares had fallen by 1.9% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 20%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Cerus Corp is
$4.00
This summary was machine generated from LSEG data March 5 at
11:28 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.02 -0.01 Beat
Sep. 30 2023 -0.05 -0.03 Beat
Jun. 30 2023 -0.06 -0.06 Met
Mar. 31 2023 -0.07 -0.09 Missed